1. Home
  2. ORIC vs VACH Comparison

ORIC vs VACH Comparison

Compare ORIC & VACH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORIC
  • VACH
  • Stock Information
  • Founded
  • ORIC 2014
  • VACH 2023
  • Country
  • ORIC United States
  • VACH United States
  • Employees
  • ORIC N/A
  • VACH N/A
  • Industry
  • ORIC Biotechnology: Pharmaceutical Preparations
  • VACH
  • Sector
  • ORIC Health Care
  • VACH
  • Exchange
  • ORIC Nasdaq
  • VACH NYSE
  • Market Cap
  • ORIC 362.9M
  • VACH 329.2M
  • IPO Year
  • ORIC 2020
  • VACH 2024
  • Fundamental
  • Price
  • ORIC $11.10
  • VACH $10.41
  • Analyst Decision
  • ORIC Strong Buy
  • VACH
  • Analyst Count
  • ORIC 9
  • VACH 0
  • Target Price
  • ORIC $18.29
  • VACH N/A
  • AVG Volume (30 Days)
  • ORIC 949.2K
  • VACH 107.1K
  • Earning Date
  • ORIC 08-11-2025
  • VACH 01-01-0001
  • Dividend Yield
  • ORIC N/A
  • VACH N/A
  • EPS Growth
  • ORIC N/A
  • VACH N/A
  • EPS
  • ORIC N/A
  • VACH 0.30
  • Revenue
  • ORIC N/A
  • VACH N/A
  • Revenue This Year
  • ORIC N/A
  • VACH N/A
  • Revenue Next Year
  • ORIC N/A
  • VACH N/A
  • P/E Ratio
  • ORIC N/A
  • VACH $35.21
  • Revenue Growth
  • ORIC N/A
  • VACH N/A
  • 52 Week Low
  • ORIC $3.90
  • VACH $9.95
  • 52 Week High
  • ORIC $14.67
  • VACH $11.20
  • Technical
  • Relative Strength Index (RSI)
  • ORIC 66.82
  • VACH N/A
  • Support Level
  • ORIC $10.42
  • VACH N/A
  • Resistance Level
  • ORIC $11.50
  • VACH N/A
  • Average True Range (ATR)
  • ORIC 0.62
  • VACH 0.00
  • MACD
  • ORIC -0.03
  • VACH 0.00
  • Stochastic Oscillator
  • ORIC 83.30
  • VACH 0.00

About ORIC Oric Pharmaceuticals Inc.

ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.

About VACH VOYAGER ACQUISITION CORP.

Voyager Acquisition Corp is a blank check company.

Share on Social Networks: